Possible treatment failure of artemether-lumefantrine in an Italian traveler with uncomplicated falciparum malaria.

Possible treatment failure of artemether-lumefantrine in an Italian traveler with uncomplicated falciparum malaria.

Show other versions (1)

Artemisinin-combination therapies (ACTs) are recommended for the treatment of uncomplicated malaria in endemic areas with multidrug resistant Plasmodium falciparum. We report a case of possible artemether-lumefantrine failure in an Italian traveler with uncomplicated P. falciparum malaria imported f...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ernestina Carla Repetto, Claudio Giacomazzi, Antonio Traverso
Format:	Article
Language:	English
Published:	PAGEPress Publications 2011-10-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	Malaria drug resistance
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/323
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Possible treatment failure of artemether-lumefantrine in an Italian traveler with uncomplicated falciparum malaria.
by: Claudio Giacomazzi, et al.
Published: (2011-01-01)

Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022
by: Abel Nhama, et al.
Published: (2025-07-01)

Plasmodium falciparum and Schistosoma mansoni coinfection and the side benefit of artemether-lumefantrine in malaria patients
by: Solomon M Abay, et al.
Published: (2013-06-01)

Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) for the Treatment of Uncomplicated Falciparum Malaria in Africa: A Systematic Review
by: Awoke Derbie, et al.
Published: (2020-01-01)

A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda
by: Daniel Kabonge Kaye, et al.
Published: (2008-04-01)

Malaria recrudescence after artemether-lumefantrine treatment in travellers– a hospital-based observational study and literature review
by: Jenny L. Schnyder, et al.
Published: (2025-07-01)

Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia.
by: Samuel Dunyo, et al.
Published: (2011-01-01)

Increasing day three parasitaemia is observed after treatment of patients with artemether-lumefantrine and single dose of primaquine for uncomplicated Plasmodium falciparum malaria in Arbaminch Zuria district, Southwest Ethiopia
by: Bontu Abate, et al.
Published: (2025-03-01)

Malaria Hepatopathy and Thrombocytopenia in Severe Falciparum Malaria
by: Muhammad Vitanata Arfijanto, et al.
Published: (2023-11-01)

CYP2B6*6 single nucleotide polymorphism among patients with uncomplicated malaria in Adjumani district, Uganda: Implications on efficacy of artemether-lumefantrine.
by: Martin Kamilo Angwe, et al.
Published: (2025-01-01)

CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
by: Alessandro Bartoloni, et al.
Published: (2012-05-01)

Antimalarial Drug Repurposing of Epirubicin and Pelitinib in Combination with Artemether and Lumefantrine
by: Douglas O. Ochora, et al.
Published: (2025-06-01)

Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.
by: Frank Kloprogge, et al.
Published: (2018-06-01)

Atypical presentation of falciparum malaria in a returning traveler: a diagnostic dilemma
by: N. Krishna Geetha, et al.
Published: (2024-09-01)

Impact of artemether–lumefantrine treatment, circadian rhythm, and serum replacement on the infectiousness of wild Plasmodium falciparum gametocytes to Anopheles gambiae sensu stricto mosquitoes
by: Dorin Joachim Mmasi, et al.
Published: (2025-07-01)

Nosocomial Transmission of Plasmodium falciparum Malaria, Spain, 2024
by: Manuel F. Liroa Romero, et al.
Published: (2025-06-01)

Exploring the P. falciparum antigens associated with reduced risk of malaria in pregnancy
by: Lucy Mwai, et al.
Published: (2025-07-01)

The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial.
by: Beth P Kangwana, et al.
Published: (2011-05-01)

Characterization of the malaria parasite Plasmodium falciparum Tepsin homolog
by: Stéphanie Roucheray, et al.
Published: (2025-08-01)

Audit of failure rate of Coartem to treat falciparum malaria at single fourteen day follow up
by: C.H. Vaughan Williams, et al.
Published: (2002-03-01)

Simultaneous Estimation of Artemether and Lumefantrine by RP-HPLC Method Development in Pharmaceutical Tablet Dosage Form
by: Lekhana A M, et al.
Published: (2025-01-01)

Malaria prevention in travelling children
by: S. Mathijs
Published: (2012-12-01)

Serum retinol concentration in patients with acute falciparum malaria
by: Adil Raza, et al.
Published: (2009-12-01)

Human Gene Expression in Uncomplicated Plasmodium falciparum Malaria
by: James M. Colborn, et al.
Published: (2015-01-01)

Study protocol: an open-label individually randomised controlled trial to assess the efficacy of artemether-lumefantrine prophylaxis for malaria among forest goers in Cambodia
by: Mavuto Mukaka, et al.
Published: (2021-07-01)

Malaria prophylaxis: Make the right choice for travellers with special circumstances
by: L. Baker
Published: (2011-11-01)

Emerging Molecular Mechanisms in Malaria Pathogenesis and Novel Therapeutic Approaches: A Focus on <i>P. falciparum</i> Malaria
by: Adekunle Sanyaolu, et al.
Published: (2025-07-01)

Audit of failure rate of sulfadoxine/pyrimetham combined with chloroquine to treat falciparum malaria at single fourteen-day follow-up
by: C.H. Vaughan Williams, et al.
Published: (2002-03-01)

Comparative in vitro dissolution profiles of marketed Artemether–Lumefantrine adult-dose tablets in Kinshasa, Democratic Republic of the Congo
by: Gloria Bujo Dhimbe, et al.
Published: (2025-06-01)

Therapeutic efficacy of artemether–lumefantrine in North-Eastern states of India and prevalence of drug resistance-associated molecular markers
by: Shreelekha Dutta, et al.
Published: (2025-04-01)

Asymptomatic falciparum malaria and genetic polymorphisms of Pfcrt K76T and Pfmdr1 N86Y among almajirai in northeast Nigeria
by: Sulayman Tunde Balogun, et al.
Published: (2016-03-01)

High malaria parasitemia in an Italian man and severe delayed hemolytic anemia
by: Massimiliano Lanzafame, et al.
Published: (2024-11-01)

Falciparum malaria transmission in Masvingo district, Zimbabwe: a mathematical model with varying human and mosquito populations
by: Taremba Chirigo, et al.
Published: (2025-03-01)

Asymptomatic Plasmodium falciparum infections and determinants of carriage in a seasonal malaria chemoprevention setting in Northern Cameroon and south Senegal (Kedougou)
by: Innocent M. Ali, et al.
Published: (2024-12-01)

Postpartum pituitary necrosis and hypopituitarism, a sequela of severe falciparum malaria in pregnancy – a case report
by: Moeez Ahmed, et al.
Published: (2025-01-01)

Efficacy of artemisinin-based combination therapy (ACT) in people living with HIV (PLHIV) diagnosed with uncomplicated Plasmodium falciparum malaria in Africa: a WWARN systematic review
by: Abena Takyi, et al.
Published: (2025-05-01)

Gut microbiota influences Plasmodium falciparum malaria susceptibility
by: Aly Kodio, et al.
Published: (2025-06-01)

Audit of efficacy of Coartem™ to clear plasmodium falciparum malaria parasitaemia at single forty-two day follow-up
by: C.H. Vaughan Williams, et al.
Published: (2004-07-01)

Endothelial molecule levels (VCAM-1, ICAM-1) in uncomplicated malaria cases in Lagos, Nigeria
by: Uche T. Igbasi, et al.
Published: (2024-12-01)

An Assessment of Endothelial Markers in Patients with Uncomplicated Malaria in Jazan Province, Saudi Arabia
by: Madkhali A, et al.
Published: (2025-06-01)